Innovating Works

EVENDOR ENGINEERING

Activa
INSPIRE: INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse... UNIVERSITEIT ANTWERPEN tramitó un H2020: H2020-MSCA-ITN-2019 New drug candidates often have off-target effects resulting in adverse events, thus representing a major limitation for drug R&D. Safety Pha...
2019-08-19 - 2024-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.